These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33914594)

  • 21. Neutralizing SARS-CoV-2.
    Poeschla E
    Elife; 2020 Dec; 9():. PubMed ID: 33320086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dial down the rhetoric over COVID-19 vaccines.
    Schoub BD
    S Afr Med J; 2021 Apr; 111(6):522-523. PubMed ID: 34382558
    [No Abstract]   [Full Text] [Related]  

  • 23. AACR Report on the Impact of COVID-19 on Cancer Research and Patient Care.
    Williams PA; Zaidi SK; Sengupta R
    Clin Cancer Res; 2022 Feb; 28(4):609-610. PubMed ID: 35140125
    [No Abstract]   [Full Text] [Related]  

  • 24. The Science and Art of Vaccinology During the COVID-19 Pandemic.
    Romero JR; Bernstein HH
    Pediatr Ann; 2020 Dec; 49(12):e506-e508. PubMed ID: 33290567
    [No Abstract]   [Full Text] [Related]  

  • 25. COVID-19: disease, or no disease? - that is the question. It's the dose stupid!
    Sehrawat S; Rouse BT
    Microbes Infect; 2021; 23(1):104779. PubMed ID: 33450356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19 Vaccine: Practical Clinical Considerations.
    Laine C; Cotton D; Moyer DV
    Ann Intern Med; 2021 May; 174(5):694. PubMed ID: 33769829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do not repeat mistakes from HIV in COVID-19 response.
    The Lancet Hiv
    Lancet HIV; 2021 Feb; 8(2):e59. PubMed ID: 33493437
    [No Abstract]   [Full Text] [Related]  

  • 28. Bioinformatics Analysis of SARS-CoV-2 to Approach an Effective Vaccine Candidate Against COVID-19.
    Sadat SM; Aghadadeghi MR; Yousefi M; Khodaei A; Sadat Larijani M; Bahramali G
    Mol Biotechnol; 2021 May; 63(5):389-409. PubMed ID: 33625681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2 Vaccines: Much Accomplished, Much to Learn.
    Connors M; Graham BS; Lane HC; Fauci AS
    Ann Intern Med; 2021 May; 174(5):687-690. PubMed ID: 33460347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How to redesign COVID vaccines so they protect against variants.
    Callaway E; Ledford H
    Nature; 2021 Feb; 590(7844):15-16. PubMed ID: 33514888
    [No Abstract]   [Full Text] [Related]  

  • 31. A rational approach to COVID-19.
    Mehrian-Shai R
    Hum Genomics; 2020 Dec; 14(1):47. PubMed ID: 33353565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Consequences of COVID-19 for cancer care - a CRUK perspective.
    Greenwood E; Swanton C
    Nat Rev Clin Oncol; 2021 Jan; 18(1):3-4. PubMed ID: 33097915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What Are COVID-19 Vaccines?
    Hartert TV; Sockrider M
    Am J Respir Crit Care Med; 2021 May; 203(9):P22-P23. PubMed ID: 33759735
    [No Abstract]   [Full Text] [Related]  

  • 34. COVID-19 Vaccines: Current Understanding on Immunogenicity, Safety, and Further Considerations.
    He Q; Mao Q; Zhang J; Bian L; Gao F; Wang J; Xu M; Liang Z
    Front Immunol; 2021; 12():669339. PubMed ID: 33912196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID vaccines and breastfeeding: what the data say.
    Hall S
    Nature; 2021 Jun; 594(7864):492-494. PubMed ID: 34163051
    [No Abstract]   [Full Text] [Related]  

  • 36. Efforts towards a COVID-19 vaccine.
    Brüssow H
    Environ Microbiol; 2020 Oct; 22(10):4071-4084. PubMed ID: 32893468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19 in patients with cancer: managing a pandemic within a pandemic.
    Horn L; Garassino M
    Nat Rev Clin Oncol; 2021 Jan; 18(1):1-2. PubMed ID: 33060841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates.
    Ura T; Yamashita A; Mizuki N; Okuda K; Shimada M
    Vaccine; 2021 Jan; 39(2):197-201. PubMed ID: 33279318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The 2020 race towards SARS-CoV-2 specific vaccines.
    Karpiński TM; Ożarowski M; Seremak-Mrozikiewicz A; Wolski H; Wlodkowic D
    Theranostics; 2021; 11(4):1690-1702. PubMed ID: 33408775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The COVID-19 exit strategy-why we need to aim low.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2021 Mar; 21(3):297. PubMed ID: 33581748
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.